{"disease":{"id":"human-metapneumovirus-infection","name":"human metapneumovirus infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03460171","title":"Clinical Features, Outcome and Prognosis of Human Metapneumovirus (hMPV) Lower Respiratory Tract Infections in Adult Inpatients","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03392389","title":"Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT04144348","title":"Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT04933968","title":"Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT04431050","title":"Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens","phase":"","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Imperial College London","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}